Pyran copolymer, a known immunostimu- Single-stranded homopolymers of ribonucleotides are reported to be inhibitory to viral RNA-dependent DNA polymerase (6, 7). This observation suggests to us that it may be possible to design molecules that will possess some relationship to the template of the reaction.
The current investigations were initiated with the intention of obtaining a specific inhibitor of DNA polymerase (deoxynucleosidetriphosphate: DNA deoxynucleotidyltransferase; EC 2.7.7.7) of RNA tumor viruses. Such an inhibitor might be of major use in biological experiments. Based on the assumption that the synthesis of DNA with sequences that are potentially oncogenic may be catalyzed by this enzyme, specific inhibitors may also be of practical interest. A great variety of compounds have been tested, of which a large number have inhibitory activity (1) (2) (3) (4) (5) (6) . Although in many cases the mechanism of action is not known, most of the compounds interfere with the binding of the template to the enzyme (7, 8) , either by direct interaction with the template or by competing with the template for the enzyme (6) .
Single-stranded homopolymers of ribonucleotides are reported to be inhibitory to viral RNA-dependent DNA polymerase (6, 7) . This observation suggests to us that it may be possible to design molecules that will possess some relationship to the template of the reaction.
The active compounds studied are pyran copolymers, the structure of which is shown in Scheme 1. It is a copolymer of approximate molecular weight of 17,000. It is a divinyl ether of maleic anhydride which, in the presence of H20, becomes hydrolyzed to the corresponding polyearboxylic acids. The compound is stable to chemical and enzymatic hydrolysis; it cannot serve as a template in the polymerase reaction.
The highly negative charges mimic the negative charges of the nucleotide templates.
In this report we describe the mechanism of action of pyran on the purified RNA-dependent DNA polymerase from avian myeloblastosis virus (AMY) obtained by the procedure of Kacian et al. (9) .
MATERIALS AND METHODS
Reagents. Unlabeled et al. (11) . Reptilian C-type particles were isolated from supernatant fluid of chronically infected viper cell line VSW (12) .
Enzymes. RNA-dependent DNA polymerase from avian myeloblastosis virus was isolated and purified as described by Kacian et al. (9) . The purified fraction shows two distinct bands on sodium dodecyl sulfate disk-gel electrophoresis, representing the two nonidentical subunits. Purified enzyme was used for subsequent studies. -Assay condition are those of Kacian et al. (9) .
DNA-deperident RNA polymerase from Escherichia coli was purified by the procedure of Berg et al. (13) and was a gift from Dr. Robert Lazzarini. Assay conditions are those of Berg.
DNA-dependent DNA polymerase from E. coli was purchased from Biopolymers Laboratory, Dover, N.J. and was assayed as described by Richardson et al. (14) .
DNA-dependent DNA polymerase from Micrococcus luteus was purchased from P-L Biochemicals and was assayed by procedure of Bollum (15) .
RNA-dependent DNA polymerase from reptilian C-type particle was isolated and partially purified by chromatography on phosphocellulose (16). Material containing peak activity was used for experiments described below. Assay conditions used are the same as those of AMV DNA polymerase.
DNA polymerases I and II from normal human-blood lymphocytes were kindly donated by Drs. R. G. Smith and R. C. Gallo. Assay conditions are those of Smith (26) .
Assay of RNA-Dependent DNA Polymerases from RLV and PK15 C-Type Particle. Conditions for assay are essentially the same as those for A-particle (17) . The reaction mixture contained, in a final volume of 25 Ail: 50 mM Tris -HC] (pH 8.3), 25% (v/v) glycerol, 370 ug/ml of bovine-serum albumin, 75 mM KCl, 0.5 mM MnCl2, 1 mM dithiothreitol, 0.33% (v/v) Nonidet P-40, 0.5 mM ATP, 100 ug/ml of poly(dA-dT), enzyme as shown in the legend of Table 4 , and 0.125 mM [3H]TTP (80-300 cpm/pmol). The reaction mixture was incubated at 370 for 45 min; it was stopped by transfer of the tubes to a 0-1' waterbath and addition of 100 ,4l of a solution containing 2 Ag/ml of bovine-serum albumin, 2 ,g/ml of yeast RNA, and 100 mM pyrophosphate followed by 1 ml of ice-cold 10% trichloroacetic acid. After 10 min at 00, acid-insoluble material was collected on a Whatman GF/C filter. The filters were washed with 10% trichloroacetic acid, and radioactivity was determined by scintillation counting.
Templates. Poly(rA) * (dT)1o, poly(dA-dT), oligo(dT)jo were purchased from Collaborative Research, Inc. Native calfthymus DNA was activated by a mild deoxyribonuclease treatment as described by Schlabach et al. (18) . Highmolecular-weight 70S RNA from AMV was extracted by the procedure of Stephenson et al. (19) 
RESULTS
Inhibition of AMV DNA Polymerase Activity by Pyran Copolymers of Various Viscosities. Pyran copolymers of various viscosities were tested for their ability to inhibit DNA synthesis of AMV DNA polymerase, in an effort to determine whether a correlation exists between viscosity and polymerase inhibitory activity. Although such correlation is not complete (Table 1) , high-viscosity compounds showed greater inhibition. All subsequent studies were carried out with compounds that possess maximal inhibitory activity, the preparation that gave viscosity of 0.425 centipoises.
Effect of Pyran on DNA Synthesis Directed By Poly(dA-dT). Increasing concentration of pyran was followed by an increase in inhibition (Fig. 1) (Fig. 2) . This result indicates (a) that the inhibitor interacts with the enzyme but not with the template, and (b) the inhibitor does not affect the binding of the template to the enzyme. Incubation time was 30 min with 6 gg/ml of AMV DNA polymerase and 0.4 A unit of poly(dA-dT). t lox indicates a 10-fold increase in enzyme or substrate concentration. Effect of Pyran on DNA Synthesis As a Function of Length of Incubation. The aforementioned studies indicated that template and pyran interact at different sites on the polymerase molecule. The question was now asked whether the enzyme can be protected from this inhibition by the substrates of the reaction. In these experiments, pyran was added either at 0 time or at 10 min after the initiation of the polymerization reaction. Results shown in Fig. 3 demonstrate that addition of pyran at 0 time or 10 min after the start of DNA synthesis resulted in an immediate inhibition of the polymerase. It is suggested from this data that pyran appears to interact at a site other than the catalytic site since the presence of the substrates did not protect the catalytic site. The classical noncompetitive nature of inhibition (Fig. 2) and the immediate cessation of the polymerization reaction (Fig. 3B) suggested that the inhibitor interfered with the initiation or elongation phase of the polymerization process rather than with initial binding of template to enzyme.
Effect of Pyran on DNA Polymerases. To determine whether pyran shows any specific inhibition with respect to other polymerases, we tested the effect of pyran on a variety of polymerases (Table 4) . Four of these are RNA-dependent DNA polymerases from diverse origin: avian, murine, reptilian, and porcine; three are bacterial polymerases; and Reaction conditions were the same as those in legend of Fig. 1 . In all experiments, template poly(dA-dT) was added at a concentration of 0.4 A units/ml. With the exception of RLV and PK15 C-type virus, which were used as particles, all other polymerases were purified fractions. two are major mammalian polymerases. All four viral polymerases were inhibited by pyran. The highest inhibition was that of AMV polymerase. However, E. coli and M. tuteus were activated under the same conditions. Both mammalian polymerases were inhibited, but the rate of inhibition was much lower than that of the viral enzymes. These results indicated that pyran shows some specificity for viral polymerases, suggesting a common structural feature at the active site of all these enzymes.
DISCUSSION
Pyran copolymer possesses many biological activities. It is an immunostimulator (20) and an interferon inducer (21) , and possesses antiviral and antitumor activities (22, 23) . The inhibition reported herein of oncornaviral polymerase activity may be of value in elucidating its antiviral activity.
Inhibitors of viral polymerases are important tools in helping to explain the role of these enzymes in viral replication and cell transformation. Specificity of these inhibitors is of extreme importance. Compounds that inhibit the enzyme by interacting with the template are less likely to be specific since they would interact with the template of other normal cellular polymerases. On the other hand, compounds such as pyran, which inhibit by interacting with the enzyme, are more likely to show specificity for the viral polymerases.
The noncompetitive inhibition kinetics of pyran with the template (Fig. 2) indicates that it interferes with the enzyme by binding at a site other than the catalytic site, resulting in a possible conformational change. Conceivably, the highly negatively charged molecule complexes with a positive nonpyran on RNA-dependent DNA polymerase is different from that of synthetic polynucleotides. Thus, pyran inhibits the reaction by not competing directly for the template site on the enzyme.
Pyran copolymer offers some similarities to nucleic acid templates by being polymeric and possessing a highly negative charge, with the added feature of not being able to serve as template for transcription or translation. Furthermore, it cannot be hydrolyzed by cellular degradative enzymes, as is the case of most polynucleotides used as inhibitors.
It has recently been reported (7) that analogs of polynucleotides can interfere effectively with virus replication in tissue culture and with the activity of viral RNA-directed DNA polymerase in vitro. Macromolecules such as these, as well as pyran, are taken into the cells through pinocytosis rather than by simple diffusion through the cell membrane. Since high pinocytotic activity appears to be characteristic of many tumor cells, macromolecules could be expected to be taken up preferentially by some type of neoplastic cells (24, 25) .
